KOSPI · Healthcare · ₩516B
₩10,020+1.73%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 12.1% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“해외 성장 기대는 유지되지만 실적 확인이 먼저예요.”
In the company's words · 2026 2분기 filing